LINC01031

Across TCGA pan-cancer cohorts, LINC01031 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC01031’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01031 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01031 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and LUAD are the cancer types where LINC01031 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01031 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	−0.381	<.001	11	view →
KIRP	Male	II,III,IV	−0.421	<.001	10	view →
LUAD	Female	III,IV	−0.676	<.001	9	view →
LUSC	Female	II,III,IV	−0.967	<.001	8	view →
KICH	Female	All	−0.443	<.001	5	view →
COAD	All	All	+0.060	.019	3	view →
PRAD	All	All	+0.570	<.001	2	view →
PAAD	Female	All	+0.300	.034	2	view →
CHOL	Male	All	+0.128	.019	2	view →
STAD	Male	II,III,IV	+0.115	.032	2	view →
THCA	All	All	−0.054	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC01031–KIRC

Open the KIRC breakdown →